康复期血捐赠者和接受者的凝血概况
Hanna H Pitkänen1,2,3, Tuukka Helin4, Tamim Khawaja5,6,7,8
1Helsinki University Hospital, Division of Anesthesiology, Department of Anesthesiology, Intensive Care and Pain Medicine, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
概括
针对COVID-19的低滴度康复性等离子体 (LCP) 治疗增加了威尔布兰德因子抗原 (VWF:Ag) 的水平,并增强了血栓生成 (TG),表明比高滴度CP (HCP) 更大的高凝血能力. HCP可能与较少的前凝效应有关.
科学领域:
- 血液学 血液学 血液学
- 传染性疾病 传染性疾病
- 免疫学 免疫学 免疫学
背景情况:
- 康复性血 (CP) 治疗COVID-19的疗法已经显示出可变的疗效,潜在的前凝剂效应引发了安全问题.
- 了解CP对凝血概况的影响对于优化其治疗用途至关重要.
研究的目的:
- 调查低位数 (LCP) 和高位数 (HCP) 康复性血对住院COVID-19患者的凝血概况的影响.
主要方法:
- 一个双盲随机试验,涉及54名接受安慰剂,LCP或HCP的患者.
- 在供体和受体血液样本中评估凝血生物标志物,抗脂抗体和血栓生成 (TG).
- 分析包括例行实验室检测,VWF:Ag水平,狼抗凝剂和内源性血栓潜力 (ETP).
主要成果:
- 与HP接收者相比,LCP接收者显示VWF:Ag水平增加和增强的TG (更高的ETP和高峰TG),尽管进行了血栓预防.
- 医疗保健专家组表现出较低的基线和第一天血小板计数比LCP组.
- 狼抗凝剂在所有组中的80%呈阳性.
结论:
- 低滴度康复性血 (LCP) 的使用增加了VWF:Ag并增强了血栓生成,表明更大的高凝血能力.
- 高滴度康复性血 (HCP) 似乎比LCP更少诱导高凝血能力.
- 这些发现可能解释了在COVID-19的CP治疗中观察到的可变疗效.
相关概念视频
Blood Transfusion and Agglutination
10.7K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
10.7K
Blood Transfusion
472
Blood transfusion is a critical medical procedure that saves lives and treats various medical conditions. It involves transferring blood from a donor to a recipient. This process requires a thorough understanding of the ABO blood group system and its associated antigens and antibodies.
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
Blood Transfusion Overview
A blood transfusion is a medical procedure used to replace blood lost due to injury, surgery, or to treat conditions such as anemia or cancer. During a transfusion, donor blood is...
472
Coagulation
4.3K
The coagulation phase is a critical part of the body's process to prevent blood loss following injury to blood vessels. It involves chemical reactions that form a clot to seal the injured area. The clotting process begins shortly after injury, within 15-20 seconds for severe damage and 1-2 minutes for minor injuries.
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
4.3K


